New Progress in Intravitreal Delivery

Session details:

Intravitreal delivery remains essential for treating retinal diseases, yet challenges around durability, safety and patient burden persist. This session will highlight recent advancements in delivery technologies, sustained release approaches and innovative formulations designed to extend dosing intervals and improve outcomes.